4DMedical Limited (ASX:4DX) Secures $22.6M Through Option Exercises
4DMedical (ASX:4DX) raises $22.6 million through option exercises, enhancing its cash position to $45.5 million for strategic growth.
Tag: Investor Relations
OpenLearning Limited (ASX:OLL) Signs SaaS Agreement with University of the Philippines Manila
OpenLearning (ASX:OLL) signs first SaaS agreement with University of the Philippines Manila, marking a strategic expansion in higher education market.
The Calmer Co. International Limited (ASX:CCO) Reports $8M Revenue in FY25
The Calmer Co (ASX:CCO) reports $8M revenue in FY25, achieving 86% growth and setting sales records in Q1 FY26.
Race Oncology (ASX:RAC) Discovers RCDS1 Mechanism of Action
Race Oncology (ASX:RAC) announces the discovery of RCDS1’s primary anticancer mechanism, enhancing its clinical and commercial potential.
Yandal Resources (ASX:YRL) Announces $13.5M Placement to Expand Exploration
Yandal Resources (ASX:YRL) raises $13.5M in placement to accelerate its exploration programs, supported by major shareholders.
Ryzon Materials Ltd (ASX:RYZ) Expands Engineering Agreement and Secures Capital Raising with Xinhai
Ryzon Materials (ASX:RYZ) expands engineering agreement and raises capital with Xinhai to advance the Nachu Graphite Project.
OzAurum Resources Limited (ASX:OZM) Accelerates Mulgabbie North Development with New RC Drilling Program
OzAurum Resources (ASX:OZM) initiates new RC drilling at Mulgabbie North, enhancing gold resource development amid record gold prices.
Bio-Gene Technology Limited (ASX:BGT) Announces Positive Flavocide Efficacy Results
Bio-Gene Technology Limited (ASX:BGT) reports over 90% tick mortality with Flavocide, driving an 87% increase in its stock price.
Tamboran Resources Corporation (ASX:TBN) Reaches Final Investment Decision for Shenandoah South Pilot Project
Tamboran Resources Corporation (ASX:TBN) announces Final Investment Decision for Shenandoah South Pilot Project, targeting mid-2026 gas sales.
Micro-X Ltd (ASX:MX1) Awarded $4.4M Grant for Ambulance Head CT Trials
Micro-X Ltd (ASX:MX1) secures a $4.4M grant to trial its innovative Head CT device in ambulances, enhancing stroke diagnosis and treatment.